CLINICAL_TRIALS
trial_result
· 2011-03-30
Clinical Trial Update: Ph II Study of Azacitidine in Myelofibrosis [Phase 2]
Summary
A Phase II study of azacitidine in myelofibrosis has completed and results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2011-03-30